The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Approval Status:

Approved December 1997

Specific Treatments:


Find Related Trials for The Following Conditions

General Information

Timentin, a Ticarcillin disodium and clavulante potassium injection, has been approved for use in children three months to 16 years of age.